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Radiotherapy with proton and ion beams is currently in a 
phase where the facility concepts of the first generation are 
slowly shifting towards new accelerator concepts. In addition 
the majority of the new facilities is equipped with scanning 
beam delivery systems. In the first generation facilities 
“standard” accelerators were used, meaning cyclotrons and 
synchrotrons, which were not specifically designed to be very 
small. Moreover, the vast majority of these systems are 
equipped with so-called passive beam delivery systems. In 
the meantime there exist several concepts for compact 
accelerators, like laser induced particle acceleration, 
dielectric-wall accelerators, very compact gantry mounted 
cyclotrons and compact synchrotrons. Only the latter two 
concepts have been realized, however, in clinical facilities, 
aiming to provide smaller and thus also cheaper single room 
facilities.  
In contrast, the optimization of beam delivery concepts and 
especially fast scanning techniques for the treatment of 
moving tumors may have a stronger impact for the patients 
already on the short term. Besides fast energy switching the 
scanning speed is optimized in this case, to provide a 
drastically shortened treatment time and the potential for 
rescanning within a short time. Many of these improvements 
and developments are concentrating on proton therapy only, 
but also in the case of carbon ion facilities there is a 
continuous improvement of the classical synchrotron 
concepts towards fast switching of beam parameters to 
provide fast scanning and rescanning. In addition the first ion 
beam gantry came into clinical operation and novel, more 
compact, gantry concepts are under investigation. An 
overview of the latest developments, its status and 
perspectives is given in the presentation.  
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Currently newly built particle therapy centers are mostly 
equipped with scanning beams, since they provide highly 
conformal dose distributions when treating static targets. 
However, scanned beams face significant challenges when 
applied to moving targets.  In addition to blurring effects, 
dose inhomogeneities can appear anywhere within a 
treatment field due to interplay between the delivery-time-
line and the time-line of motion. To mitigate motion effects, 
different approaches have been suggested. As the simplest 
solution, one can try to reduce the motion during treatment 
delivery through, for example, breath hold or gating 
techniques.  In this talk, we would like to concentrate on 
motion mitigation techniques that are unique for a scanned 
beam delivery, namely rescanning and tracking. 
The idea of rescanning is to statistically average out dose 
heterogeneities by repeatedly delivering the planned dose to 
the target with an accordingly reduced number of particles 
per scan. The risk of rescanning is the introduction of 
periodicity in the delivery time-line which can lead to 
interference phenomena with the periodicity of the patient 
motion. For a successful application of rescanning it is 
therefore essential to choose the right “flavor” of 
rescanning. Each specific way of scanning and each flavor of 
rescanning has its own characteristic delivery-time-line which 
is machine specific. In this presentation, we will show 
examples to emphasize that for a successful application of 
rescanning it is important to choose a way of scanning and a 
flavor of rescanning appropriate for your specific facility and 
adapted to the characteristics of each specific patient 
(motion characteristic, tumor size, tumor side). 
Beam tracking for particle therapy refers to the lateral 
adaptation of pencil beam position, combined with 
appropriate energy changes to modify the position of the 
Bragg peak in order to compensate for target motion in all 
directions. Tracking relies on motion monitoring; ideally, real 
time 3D imaging should be employed or alternatively pre-
treatment acquired 4DCT in combination with a motion 
surrogate. In current experiments the adaptation parameters 
are determined prior to treatment delivery based on 4DCT 
data, which leads to concerns about variations in patient 
anatomy and respiratory motion between the 4DCT scan and 
the time of treatment. For tracking, it is particularly 
important to minimize the time lag between the detection of 
a geometry change and the corresponding adaptation of the 
beam. By minimizing the time between pre-treatment 
imaging, potential online plan adaptation, and treatment 
delivery, these uncertainties can be reduced, but there is 
need to investigate the robustness of beam tracking, 
particularly over the time scales of fractionated delivery.  
An optimal outcome for moving target geometries is probably 
obtained by combining different motion mitigation 
approaches. As there exist many different motion scenarios 
there is an optimal way to account for motion effects for 
each scenario. Perhaps the ultimate solution for the 
treatment of moving targets with scanned particle beams 
would be the combination of real time tracking and 
rescanning, so called re-tracking. However, to implement this 
clinically, online on-board 3D imaging has to be improved. A 
lot of developments, simulations and verifications have to be 
performed before such a technique could be used clinically. 
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The use of radiotherapy as a method for tumor treatment is 
closely associated with toxicity in healthy tissues. Several 
methods have been developed to address this, using different 
techniques in an attempt to minimize the radiation dose to 
healthy tissues. Some techniques aim at reducing the clinical 
to planning target volume margins which account for the 
movement of the target as well as setup uncertainties. This 
presentation will focus on some of the essential interactions 
between internal and external immobilization techniques and 
image guided radiotherapy, beginning by describing three 
major factors which affect the outcome of radiotherapy: 
rotation, deformation and displacement. Some technique 
examples will be presented including immobilization of the 
prostate, the head and neck area and the rectum. The 
presentation will provide insights into the pros and cons of 
immobilization in an era of image guided radiotherapy.  
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In radiotherapy of cancer patients, accurate dose delivery is 
of the utmost importance. Not only to deliver the required 
dose to the tumor, but also to minimize the dose to the 
surrounding healthy tissue. Setup verification is therefore an 
essential part in the radiotherapy chain. Since the late 1950’s 
to present day, setup verification using in-room imaging, has 
evolved dramatically. As a result of this the role and 
responsibilities of the RTT’s in assessing these images and the 
impact on patients’ treatment has changed accordingly. 
Initially, the most commonly used in-room imaging modality 
was megavoltage films. Only the bony structures could be 
visualized on these films. The RTT or the physician checked 
the position of the patient using these films, typically only 
during the first treatment session.  
A big step forward occurred in the 1990’s with the 
introduction of portal imaging as a digital replacement of 
megavoltage films. The images were directly available and 
registration was automated. However, anatomical 
information was still limited and in 2D. The most used 
treatment techniques (AP/PA, 3vs or 4vs) resulted in large 
treatment fields and unnecessary irradiation of healthy 
tissue.  
Not only bony structures, but also soft tissue can be 
visualized more accurately with the introduction of advanced 
in-room imaging techniques in the beginning of this century, 
like CT-on rails and Cone-Beam CT. Also advanced treatment 
techniques like IMRT and VMAT are becoming standard 
clinical practice. Together with improved in-room imaging 
target volumes can be reduced and healthy tissue can be 
spared. An important role for the RTT´s is to verify not only 
setup but also to ascertain if changes in anatomy during the 
RT course could result in under dosage of the tumor or over 
dosage of the organs at risk, resulting in an adaptation of the 
treatment plan. Moreover, the creation of a library of plans 
and daily selection of the optimal plan based on anatomical 
information is currently being evaluated. 
In the last decade, the role of MR in radiotherapy has become 
increasingly important. The excellent soft tissue contrast of 
MR not only allows accurate tumor delineation, but also 
functional information of the tissue becomes available. As 
tumor delineation becomes more accurate, target volumes 
can be more accurately defined. 
The development towards the integration of an MR and a 
treatment machine considerably improves the soft-tissue 
contrast and even functional information is available for 
image guidance. This improved image quality has the 
potential to enable daily re-planning in clinical practice. MR 
guidance entails an important change for the RTT’s, not only 
in image evaluation but also in decision making concerning 
the treatment. Changes in tumor position or tumor behavior 
are available during treatment and personalized 
intervention/adaption of the plan becomes possible. 
Conclusion: In-room image guidance is continuously evolving 
from setup verification on low contrast 2D megavoltage films 
with standardized treatment fields, towards MR guidance and 
adaptation, minimizing target volumes and optimizing 
treatment for the individual patient. 
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Survival rates for lung cancer patients treated with 
radiotherapy (RT) are poor partly due to the high rates of 
local recurrence. It has been shown that the local control 
rate may be improved for non-small cell lung cancer patients 
by increasing the RT dose. However, this requires high 
precision in the daily RT delivery, in order to minimize 
margins and avoid unacceptable normal tissue toxicity. 
Large treatment margins have been used for lung tumours to 
account for respiratory motion and interfractional changes in 
the position of the primary tumour and the lymph nodes.  
The respiratory motion may be taken into account by use of 
time resolved 4D CT scans, whereby the respiratory motion of 
the individual patient is visualized. Implementation of gated 
treatment may lead to a larger margin reduction.  The use of 
FDG-PET for target identification and delineation has 
increased the accuracy due to its high sensitivity and 
specificity. 
The anatomy of the patient may change during the treatment 
course which leads to interfrational shifts in the position of 
the tumour and the lymph nodes. The most commonly used 
setup is based on the bony anatomy of the patient. However, 
a soft tissue match using the tumour reduces the treatment 
margins significantly. Minimal margins require daily online 
tumour match using for instance CBCT scans before each 
treatment fraction. In the majority of the patients, one or 
more of the lymph nodes are found to be malignant which 
complicates the soft tissue match as the nodes and the 
primary tumour may be subject to different interfractional 
shifts and thus, setup on both targets will not be perfect. It 
was found that setup on the primary tumour lead to 
underdosage of the lymph nodes in 10% of the patients[1]. In 
order to account for this, a threshold value for the 
interfractional shift may be used to select patients with 
systematic deviations above the threshold for re-scanning and 
re-planning, i.e. adaptive radiotherapy (ART).  
ART is a radiation treatment process where the treatment 
plan can be modified using systematic feedback of 
measurements [2]. In case of anatomical changes this implies 
re-scanning and re-optimization of the treatment plan.  
Tumour shrinkage and irreproducible fixation may lead to 
systematic interfractional shift of the tumour and the lymph 
nodes. Large anatomical changes are observed in 23 % of the 
patients[3]. These changes include appearance / 
disappearance of an atelectasis, pleural effusion or 
pneumonia/pneumonitis.  These changes may lead to 
geometrical changes of the targets and/or to dosimetrical 
changes due to changes in the density of the tissue (see Fig 
1). In both cases underdosage of the tumour/lymph nodes or 
overdosage of the normal tissue may result.  It has been 
shown that anatomical changes have a larger impact on the 
dose distribution than changes in the respiratory motion or 
interfractional shifts[4]. Therefore, most patients 
experiencing anatomical changes may benefit from 
ART[3,5,6]. 
In addition, tumour shrinkage during the RT course, enables 
dose escalation to the primary tumour with without 
increasing the normal tissue toxicity[7]. 
The implementation of ART requires education of the 
radiation therapists. In our clinic, a programme with e-
learning, hands on training and an individual test was setup 
before clinical start. Furthermore, ART requires a well-
defined workflow for re-scanning and re-planning of quite a 
lot of patients. And finally, daily online soft tissue matching 
followed by evaluation of the tumour and lymph nodes will 
prolong the treatment time compared to a bony anatomy 
match. In our clinic the treatment time was prolonged by 3 
minutes. 
